Target intelligence / Profile preview

Broad cellular components

Molecular classification
Other
01

Overview

Broad cellular components is a high-level classification used to describe the various structural and functional parts of a cell, ranging from the plasma membrane to internal organelles (Gene Ontology Resource, 2021). Unlike specific molecular targets such as a single receptor or enzyme, this term refers to an aggregate of cellular machinery that maintains structural integrity and compartmentalization (Molecular Biology of the Cell, 6th Ed). In a pharmacological context, agents that interact with broad cellular components typically lack a specific binding pocket and instead exert their effects through generalized physical or chemical perturbations (Goodman & Gilman's, 13th Ed). For example, general anesthetics may act by altering the fluidity of lipid bilayers, while non-specific cytotoxic agents like certain alkylators or oxidants damage multiple cellular structures simultaneously (StatPearls, 2023). Because these components are fundamental to all living cells, drugs targeting them often exhibit a broad spectrum of activity but are frequently associated with significant off-target toxicity and a narrow therapeutic window (NCBI Bookshelf, 2022). Consequently, this term is often used in drug databases to categorize compounds with diffuse or poorly defined molecular mechanisms.

Other names
Cellular componentCellular structureNon-specific cellular targetsGeneral cellular structures
02

Mechanism of action

Non-specific physical or chemical disruption of multiple cellular structures, such as lipid bilayers, genomic DNA, or the cytoskeleton, rather than binding to a specific protein pocket.

03

Biological functions

Cellular compartmentalizationStructural integrityMetabolic homeostasisIntracellular transport
04

Disease associations

CancerInfectionInflammation
05

Safety considerations

Systemic toxicityLack of selectivityNarrow therapeutic indexOff-target effects in healthy tissues
06

Interacting drugs

Ethanol

4 more in the full profile.

Beyond the preview

Go deeper on Broad cellular components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Broad cellular components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call